Expand CORT Menu
CORT MENU

CORT Stock Posts


CORT #CorceptTherapeutics stock increases 18.3% after hours.

After Hours Gainer

CORT Corcept Therapeutics92.95-1.24-1.3%

After Hours:110.00+17.05 (+18.3%)

Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update

Business WireWed, 29-Jul 4:05 PM
Upcoming Earnings

CORT Corcept Therapeutics96.39+2.20 (+2.3%)

Corcept Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±13.9% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±5.4%. View Expected Move (Conf Call: Jul 29 5:00 PM)
Unusual Option Volume

CORT Corcept Therapeutics70.42+0.93 (+1.3%)

Corcept Therapeutics trades 2,274 contracts. The highest volume is in the 21-Aug-26 75 calls, which is 6.5% above the current price. News: Corcept Presents New Data at ASCO 2026: Lifyorli Overall Survival Across All Subgroups of Patients with Platinum-Resistant Ovarian Cancer, Including Those with Recent Taxane Exposure
View Details...
Unusual Option Volume

CORT Corcept Therapeutics64.74+4.38 (+7.3%)

Corcept Therapeutics trades 3,192 contracts. The company has the following event: 2026 American Society of Clinical Oncology (ASCO) Annual Meeting on May 29, 2026. News: Corcept to Resubmit its New Drug Application for Relacorilant as a Treatment for Patients with Cushing's Syndrome
View Details...
Unusual Option Volume

CORT Corcept Therapeutics58.10+2.98 (+5.4%)

Corcept Therapeutics trades 4,426 contracts. The company has the following event: 2026 American Society of Clinical Oncology (ASCO) Annual Meeting on May 29, 2026.
View Details...
Unusual Option Volume

CORT Corcept Therapeutics55.19+4.03 (+7.9%)

Corcept Therapeutics trades 1,707 contracts. The company has the following event: 2026 American Society of Clinical Oncology (ASCO) Annual Meeting on May 29, 2026.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes